|
PTK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18260000014914E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.16009999998157E-07 |
| Normal-vs-Stage2 |
4.384400E-04 |
| Normal-vs-Stage3 |
9.036000E-02 |
| Normal-vs-Stage4 |
5.184400E-01 |
| Stage1-vs-Stage2 |
6.135200E-01 |
| Stage1-vs-Stage3 |
8.550000E-02 |
| Stage1-vs-Stage4 |
1.374220E-01 |
| Stage2-vs-Stage3 |
2.458200E-01 |
| Stage2-vs-Stage4 |
1.815650E-01 |
| Stage3-vs-Stage4 |
7.094800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.96759999965468E-07 |
| Normal-vs-AfricanAmerican |
4.81179999956005E-07 |
| Normal-vs-Asian |
2.630400E-01 |
| Caucasian-vs-AfricanAmerican |
5.313000E-01 |
| Caucasian-vs-Asian |
3.976200E-01 |
| AfricanAmerican-vs-Asian |
1.848600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.83840001186798E-10 |
| Normal-vs-Female |
1.623420E-01 |
| Male-vs-Female |
1.001480E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.816720E-03 |
| Normal-vs-Extreme_Weight |
2.91210000002984E-06 |
| Normal-vs-Obese |
8.102100000007E-05 |
| Normal-vs-Extreme_Obese |
1.69195999999427E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.652000E-01 |
| Normal_Weight-vs-Obese |
7.207400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.640600E-01 |
| Extreme_Weight-vs-Obese |
3.318000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.974000E-01 |
| Obese-vs-Extreme_Obese |
2.076200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.077400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.8598999999977E-05 |
| Normal-vs-Age(61-80Yrs) |
7.62000018639242E-10 |
| Normal-vs-Age(81-100Yrs) |
1.125940E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.825900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.651900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.639900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.257900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.878400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.993600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.60549972894853E-10 |
| Normal-VS-Type2 PRCC |
2.09910000048552E-07 |
| Normal-VS-KIRP CIMP |
1.998980E-01 |
| Normal-VS-Unclassified PRCC |
4.183500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.846400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.555200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.662800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.31010000000454E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.167600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.297800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.03380000016485E-07 |
| Normal-vs-N1 |
5.133400E-01 |
| Normal-vs-N2 |
7.265600E-01 |
| N0-vs-N1 |
1.981630E-03 |
| N0-vs-N2 |
2.143200E-01 |
| N1-vs-N2 |
4.720400E-01 |
|
|
